Thyroid profile in newly diagnosed male HIV patients: a study from North Western part of India
DOI:
https://doi.org/10.18203/2320-6012.ijrms20173527Keywords:
CD4 cell count, Endocrine changes, Hyperthyroidism, HypothyroidismAbstract
Background: The aim of this study was to determine proportion of newly diagnosed male HIV cases with thyroid dysfunction at different levels of CD4 counts.
Methods: 195 newly diagnosed male HIV patients attending medical OPD, ART centre and medical wards of SMS Medical College and Hospital, during a period of May 2012 to April 2013 were enrolled in the study. These patients were divided in three groups on the basis of CD4 cell counts. Group A: CD4 counts <200/mm3, Group B: CD4 counts 200-499/mm3 and Group C: CD4 counts >500/mm3.
Results: We concluded a negative correlation between the CD4 counts and serum TSH level (r = -0.382) which was significant (p-value <0.05). Overall 32 (16.41%) patients had increased TSH, 4 (2.05%) patients had decreased and 159 (81.53%) patients had normal TSH level. Plasma TSH values in group A were higher than group B and C and they were highly significant (p<.001). Mean plasma TSH values in patients of group A, B and C was 4.56±3.60 µIU/mL (range: 1.10-17.74), 2.20±1.02 µIU/mL (range:0.24-4.22) and 2.23±1.06 µIU/mL (range:0.28-4.25) respectively. (Reference normal value = 0.4-4.0 µIU/mL). There was significantly positive correlation (p-value < 0.01) found between the CD4 counts and serum free T4 levels (r = +0.378).
Conclusions: This study has demonstrated a high prevalence of thyroid dysfunction in HIV infected patients of this part of country. High prevalence of thyroid dysfunction may contribute to the morbidity of the patients and have a bearing on quality of life of the HIV infected patients. Severity of hypothyroidism was correlated with decreasing CD4 cell count.
References
Danoff A. HIV and the thyroid: what every practicing endocrinologist needs to know. Nature Clin Pract Endocrinol Metabol. 2006;2(11):602-3.
Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus infected patients: A need for screening. Clin Infect Dis. 2003;37:579-83.
Bhasin S, Singh A. Neuroendocrine abnormalities associated with HIV infection. Endocrinology and Metabolism Clinics of North America. 2001;30:749-64.
Burness, Christine E, Shaw, Pamela J. Thyroid disease and the nervous system. Michael Jeffrey Neurology and General Medicine; 2008:357-81.
Unnikrishnan GA, Menon UV. Thyroid disorders in India: An epidemiological perspective. Indian J Endocrinol Metab. 2011;15(2):S78-81.
Meena LP, Rai M, Singh SK, Chakravarty J, Singh A, Goel R, et al. Endocrine changes in male HIV patients. J Assoc Phy Ind. 2011;59:365‑6.
Jain G, Devpura G, Gupta BS. Abnormalities in the thyroid function tests as surrogate marker of advancing HIV infection in infected adults. J Assoc
Phy Ind. 2009;57:508‑10.
Ketsamathi C, Jongiaroenprasert W, Chailurkit LO, Udomsubpayakul U, Kiertiburanakul S. Prevalence of thyroid dysfunction in Thai HIV infected patients. Curr HIV Res. 2006;4:463-7.
Frank TS. LiVolsi VA, Connor AM. Cytomegalovirus infection of the thyroid in immunocompromised adults. Yale J Biol Med. 1987;60:1-8.
Welch K, Finkbeiner W, Alpers CE, Blumenfeld W, Davis RL, Smuckler EA, et al. Autopsy findings in the acquired immune deficiency syndrome. JAMA. 1984;252(9):1152-9.